2020
DOI: 10.1016/j.tiv.2020.104922
|View full text |Cite
|
Sign up to set email alerts
|

Copper transporter 1 affinity as a delivery strategy to improve the cytotoxic profile of rationally designed copper(II) complexes for cancer treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
5
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(6 citation statements)
references
References 29 publications
1
5
0
Order By: Relevance
“…It is an assay used to determine the efficacy of a cytotoxic agent based on cell reproduction. Complex 1 significantly inhibited the colony area and colony intensity in a concentration-dependent manner after 48 h of treatment (Figure A), consistent with the results of MTT, reinforcing the cytotoxic and cytostatic effects of the complex. , …”
Section: Resultssupporting
confidence: 85%
See 1 more Smart Citation
“…It is an assay used to determine the efficacy of a cytotoxic agent based on cell reproduction. Complex 1 significantly inhibited the colony area and colony intensity in a concentration-dependent manner after 48 h of treatment (Figure A), consistent with the results of MTT, reinforcing the cytotoxic and cytostatic effects of the complex. , …”
Section: Resultssupporting
confidence: 85%
“…Complex 1 significantly inhibited the colony area and colony intensity in a concentration-dependent manner after 48 h of treatment (Figure 5A), consistent with the results of MTT, reinforcing the cytotoxic and cytostatic effects of the complex. 85,86 Morphological analysis of MDA-MB-231 cells treated for 48 h with different concentrations of complex 1 showed a concentration and time-dependent decrease in cell density, the appearance of round cells, and loss of cell adhesion (Figures 5B and S39), all indicative signs of cell death. 87,88 A more refined morphological analysis of the MDA-MB-231 cells was performed by phalloidin staining.…”
Section: ■ Experimental Sectionmentioning
confidence: 99%
“…Moreover, copper-containing complexes or materials also behave as bearers of high thermal and electrical conductivity, or catalytic and sensory features. As examples, the following papers could be mentioned to show the current strives on the design of copper(II) complexes showing some of the above mentioned properties, mainly the antiproliferative one [ 4 , 5 , 6 , 7 , 8 , 9 , 10 ]. To date, one of the most intensively studied groups of copper(II) complexes in terms of their possible clinical use as anticancer agents is the copper(II) complexes called Casiopeínas ® , whose composition can be expressed by the formulas [Cu( N – N )( N – O )] + and/or [Cu( N – N )( O – O )] + , where ( N – N ) represents an aromatic heterocyclic diimine, such as 2,2′-bipyridine (bpy) or 1,10-phenanthroline (phen), ( N – O ) and ( O – O ) stands for an amino acid, and acetylacetone, respectively [ 11 ].…”
Section: Introductionmentioning
confidence: 99%
“…Finally, we did not focus on the transport mechanisms of the Cu 2+ complexes in this study. Previous studies on the cytotoxicity of several copper(II) complexes for cancer treatment have demonstrated that copper transporter 1 plays critical roles in cancer cell uptake of copper(II) complexes [43]. Therefore, copper transporter 1 may also contribute to the transportation of 64 Cu 2+ -Tren and 64 Cu 2+ -Dien.…”
Section: Discussionmentioning
confidence: 99%